Myriad Genetics Financial Overview
Myriad Genetics's market cap is currently $630.12M. The company's EPS TTM is $0; its P/E ratio is -1.51; Myriad Genetics is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
